Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KERENDIA safely and effectively. See full prescribing information for KERENDIA. KERENDIA (finerenone) tablets, for oral use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
Kerendia is indicated to reduce the risk of: sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2DM). cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adult patients with heart failure with left ventricular ejection fraction (LVEF) ≥ 40%.
- generic_name
- finerenone
- product_names
- finerenone
- ndc
- 50419-540, 50419-541, 50419-542, 50419-540-01, 50419-540-02, 50419-540-70, 50419-540-06, 50419-541-01, 50419-541-02, 50419-541-70, 50419-541-06, 50419-542-01, 50419-542-02, 50419-542-70, 50419-542-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en